FDA Greenlights Cancer Detection AI Tools From Two RadNet Subsidiaries

Fresh from the news that their diagnostic imaging parent company is boasting an 8.4% first-quarter revenue increase year-over-year, two RadNet Inc. subsidiaries have scored FDA approval for their AI-centric mammography and prostate tools...